Latest News

Wizz Air passenger numbers surge in July
Low-cost European carrier Wizz Air said on Tuesday that passenger numbers surged in July as the group continued to grow its network amid a gradual return for international travel demand.
Aferian H1 profits grow amid 'significant progress'
Media technology group Aferian said on Tuesday that interim profits had improved and that it had made "significant progress" against its 2025 strategic goals.
Aeorema H1 revenues expected to be best ever
Live-events agency Aeorema said on Tuesday that the outlook for the start of the new financial year was "very strong", with first-half revenues anticipated to be greater than any previous interim period on record.
Cambridge Cognition turns in 'strong financial performance' in H1
Software firm Cambridge Cognition said on Tuesday that it had put on a "strong financial performance" in the six months ended 30 June, with both revenue and sales growth during the period.
DuPont beats Q2 expectations, raises FY guidance for a second time
Chemicals firm DuPont upped its full-year guidance for a second time on Tuesday after increased demand and higher prices aided the firm in beating second-quarter expectations.
Broker tips: Rightmove, HSBC
Berenberg upgraded Rightmove to 'hold' from 'sell' on Tuesday and hiked the price target to 710. 0p from 455. 0p as it said the stock's valuation was full but "not extreme".

US close: Stocks mixed at the end of August's first session
Wall Street stocks closed in a mixed state on Monday, as market participants made it through the first trading day of August.

Wednesday preview: Global services PMIs, Taylor Wimpey in the spotlight
Financial markets' focus in the middle of the week will shift to global services with a raft of surveys covering the sector's health due out from around the world.

Credit Suisse stays 'underweight' on non-financial cyclicals but adds to miners
Analysts at Credit Suisse reiterated their 'underweight' stance for most European non-financial cyclicals on valuation grounds - but not on miners.

Europe close: Corporate earnings buoy stocks
European shares stayed in record territory on Tuesday, boosted by another raft of strong corporate earnings and return of dividend payouts from the likes of BP.

London close: Stocks finish firmer as BP and banks lift FTSE
London stocks managed a positive finish on Tuesday, underpinned by well-received earnings from the likes of BP and Standard Chartered.

Director dealings: Big Yellow CEO makes share sale
Big Yellow Group revealed on Tuesday that chief executive James Gibson had sold 300,000 shares in the FTSE 250-listed self-storage firm.

Dalio says Beijing's crackdown on technology firms has been misinterpreted
Beijing's recent crackdown on technology and education stocks was misinterpreted by Western investors as "anti-capitalist", a well-known hedge fund manager said.

Immotion strikes deal for VR theatre at Sea Life Orlando
Virtual reality (VR) company Immotion announced on Tuesday that it has agreed to install a new 16-seat theatre-style installation at the Sea Life Orlando aquarium in Florida, part of the Merlin Entertainments group.

Wolverine Worldwide acquires women's sportswear brand Sweaty Betty
Merrell and Saucony parent company Wolverine Worldwide has acquired Lululemon competitor Sweaty Betty from private equity firm L Catterton for $410. 0m.

Seed Innovations puts another £0.22m into hemp firm Yooma
Medical cannabis and health and wellness-focussed investor Seed Innovations has participated in the latest financing round of $9. 7m (£6. 96m) by its portfolio company Yooma Wellness, it announced on Tuesday.

FTSE 250 movers: Babcock bounces back; Rotork shares fall
London’s FTSE 250 was up 0. 3% at 23,284. 38 in afternoon trade on Tuesday.

US open: Stocks mixed as Covid-19 concerns weigh on reopening plays
Wall Street stocks were mixed early on Tuesday as Covid-19 concerns weighed on reopening plays.

FTSE 100 movers: BP gushes higher on results; Smiths Group tumbles
London’s FTSE 100 was up 0. 3% at 7,100. 31 in afternoon trade on Tuesday.

Sanofi to buy Translate Bio to boost mRNA capabilities
French pharmaceuticals group Sanofi has agreed to buy US clinical stage mRNA therapeutics company Translate Bio in a $3. 2bn deal.
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.